Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Vascular relaxation, antihypertensive effect, and cardioprotection of a novel peptide agonist of the Mas receptor

Item Type:Article
Title:Vascular relaxation, antihypertensive effect, and cardioprotection of a novel peptide agonist of the Mas receptor
Creators Name:Savergnini, S.Q. and Beiman, M. and Lautner, R.Q. and de Paula-Carvalho, V. and Allahdadi, K. and Pessoa, D.C. and Costa-Fraga, F.P. and Fraga-Silva, R.A. and Cojocaru, G. and Cohen, Y. and Bader, M. and de Almeida, A.P. and Rotman, G. and Santos, R.A.
Abstract:Mas stimulation with angiotensin (Ang)-(1-7) produces cardioprotective effects and vasorelaxation. Using a computational discovery platform for predicting novel naturally occurring peptides that may activate G protein-coupled receptors, we discovered a novel Mas agonist peptide, CGEN-856S. An endothelium- and NO-dependent vasodilating effect was observed for CGEN-856S in thoracic aorta rings of rats (maximal value for the relaxant effect: 39.99+/-5.034%), which was similar to that produced by Ang-(1-7) (10(-10) to 10(-6) mol/L). In addition, the vasodilator activity of this peptide depended on a functional Mas receptor, because it was abolished in aorta rings of Mas-knockout mice. CGEN-856S appears to bind the Mas receptor at the same binding domain as Ang-(1-7), as suggested by the blocking of its vasorelaxant effect with the Ang-(1-7) analogue D-Ala(7)-Ang-(1-7), and by its competitive inhibition of Ang-(1-7) binding to Mas-transfected cells. The effect of CGEN-856S on reperfusion arrhythmias and cardiac function was studied on ischemia reperfusion of isolated rat hearts. We found that picomolar concentration of CGEN-856S (0.04 nmol/L) had an antiarrhythmogenic effect, as demonstrated by a reduction in the incidence and duration of reperfusion arrhythmias. Furthermore, acute infusion of CGEN-856S produced a shallow dose-dependent decrease in mean arterial pressure of conscious spontaneously hypertensive rats. The maximum change during infusion was observed at the highest dose. Strikingly, blood pressure continued to drop in the postinfusion period. The results presented here indicate that the novel Mas agonist, CGEN-856S, might have a therapeutic value, because it induces vasorelaxing, antihypertensive, and cardioprotective effects.
Keywords:Mas1, Angiotensin (1-7), Hypertension, Reperfusion Arrhythmias, Animals, Mice, Rats
Source:Hypertension
ISSN:0194-911X
Publisher:American Heart Association (U.S.A.)
Volume:56
Number:1
Page Range:112-120
Date:July 2010
Official Publication:https://doi.org/10.1161/HYPERTENSIONAHA.110.152942
PubMed:View item in PubMed

Repository Staff Only: item control page

Open Access
MDC Library